​

Connect Biopharma Ownership | Who Owns Connect Biopharma?

OverviewForecastChart

Connect Biopharma Ownership Summary

Connect Biopharma is owned by 5.12% institutional investors, 40.81% insiders, and 54.07% retail investors. Blackrock is the largest institutional shareholder, holding 188.61% of CNTB shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.05% of its assets in Connect Biopharma shares.

CNTB Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockConnect Biopharma5.12%40.81%54.07%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock103.89K188.61%$157.91K
Bml capital management2.09M3.80%$2.89M
Ubs oconnor510.70K0.93%$704.77K
Choreo160.87K0.29%$204.22K
Renaissance134.70K0.24%$185.88K
Royal bank of canada80.40K0.15%$111.00K
Callan capital80.00K0.15%$110.40K
Geode capital management27.96K0.05%$38.59K
Commonwealth equity services20.00K0.04%$28.00K
Rhumbline advisers9.50K0.02%$13.11K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bml capital management2.09M1.79%$2.89M
Ubs oconnor510.70K0.06%$704.77K
Callan capital80.00K0.01%$110.40K
Choreo160.87K0.00%$204.22K
Renaissance134.70K0.00%$185.88K
Catalina capital group---
Geowealth management---
Jpmorgan chase121.00-$167.00
Ubs group4.73K-$6.53K
Royal bank of canada80.40K-$111.00K

Top Buyers

HolderShares% AssetsChange
Choreo160.87K0.00%160.87K
Royal bank of canada80.40K-49.80K
Callan capital80.00K0.01%38.18K
Ubs group4.73K-4.73K
Morgan stanley3.57K-3.57K

Top Sellers

HolderShares% AssetsChange
Blackrock103.89K--936.18K
Catalina capital group---47.87K
Renaissance134.70K0.00%-40.80K
Keudell/morrison wealth management---33.45K
Geowealth management---10.94K

New Positions

HolderShares% AssetsChangeValue
Choreo160.87K0.00%160.87K$204.22K
Ubs group4.73K-4.73K$6.53K
Morgan stanley3.57K-3.57K$5.42K

Sold Out

HolderChange
Qube research-46.00
Blackrock funding, inc. /de-1.84K
Two sigma investments, lp-10.80K
Geowealth management-10.94K
Keudell/morrison wealth management-33.45K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202513-13.33%2,827,742-11.11%515.40%2-75.00%4300.00%
Dec 31, 20241536.36%3,181,0278.02%520.23%860.00%1-
Sep 30, 202411-8.33%2,944,726-1.06%518.33%566.67%1-75.00%
Jun 30, 2024129.09%2,976,236-24.60%510.51%350.00%4-
Mar 31, 202411-26.67%3,947,159-44.56%74.29%2-71.43%4-33.33%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Nasdaq Composite Index27.96K0.05%-

CNTB Ownership FAQ

Who Owns Connect Biopharma?

Connect Biopharma shareholders are primarily institutional investors at 5.12%, followed by 40.81% insiders and 54.07% retail investors. The average institutional ownership in Connect Biopharma's industry, Biotech Stocks , is 63.96%, which Connect Biopharma falls below.

Who owns the most shares of Connect Biopharma?

Connect Biopharma’s largest shareholders are Blackrock (103.89K shares, 188.61%), Bml capital management (2.09M shares, 3.80%), and Ubs oconnor (510.7K shares, 0.93%). Together, they hold 193.33% of Connect Biopharma’s total shares outstanding.

Does Blackrock own Connect Biopharma?

Yes, BlackRock owns 188.61% of Connect Biopharma, totaling 103.89K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 157.91K$. In the last quarter, BlackRock decreased its holdings by -936K shares, a -90.01% change.

Who is Connect Biopharma’s biggest shareholder by percentage of total assets invested?

Bml capital management is Connect Biopharma’s biggest shareholder by percentage of total assets invested, with 1.79% of its assets in 2.09M Connect Biopharma shares, valued at 2.89M$.

Who is the top mutual fund holder of Connect Biopharma shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Connect Biopharma shares, with 0.05% of its total shares outstanding invested in 27.96K Connect Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools